HIGHLIGHTS
- who: Ramin Raul Ossami Saidy and colleagues from the Department of Surgery, Campus Charitu00e9 Mitte have published the research: A Reduction of Calcineurin Inhibitors May Improve Survivalin Patients with De Novo Colorectal Cancer afterLiver Transplantation, in the Journal: Medicina 2022, 1755 of 20/Oct/2020
- what: Calcineurin inhibitors (CNI), mycophenolate mofetil (MMF), glucocorticoids (GC) and mammalian target of rapamycin inhibitors (mTORI) are most frequently used, and their fine-tuned regimen is one of the main reasons for the markedly prolonged survival of graft function after LT in the last decades . Certain limitations of this study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.